Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
AKB-6548, a new hypoxia-inducible factor prolyl hydroxylase inhibitor increases hemoglobin while decreasing ferritin in a 28-day, phase 2a dose escalation study in stage 3 and 4 chronic kidney disease patients with anemia [abstract]
may sometimes lead to the need for hemodialysis
Exenatide prolonged the gastric half-emptying time in all diabetic patients without gastroparesis ( n = 20) and worsened the gastric emptying in two of ten diabetics with pre-existing mild gastroparesis [56]
Once you start to give each injection, you cannot stop
US$ 20.92
US$ 26.00
US$ 21.27
US$ 20.52
US$ 28.52
US$ 23.92
